Duvoid and Tiotropium and olodaterol Inhalation
Determining the interaction of Duvoid and Tiotropium and olodaterol Inhalation and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using bethanechol together with tiotropium may reduce the effectiveness of one or both medications. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:GENERALLY AVOID: Anticholinergic agents and other agents with significant anticholinergic activity (e.g., clozapine, class IA antiarrhythmics especially disopyramide) may antagonize the effects of direct-acting cholinergic agents such as bethanechol, carbachol, cevimeline, and pilocarpine. This interaction is sometimes desirable and is the basis for using atropine in the treatment of excessive muscarinic side effects and cholinergic crisis induced by cholinergic overdose. Conversely, cholinergic agents may also counteract the pharmacologic effects of anticholinergic agents and other agents that rely partially on their anticholinergic activity for therapeutic effects (e.g., some antiparkinsonian and antiemetic/antivertigo agents). The mechanism of interaction involves opposing pharmacodynamic action on muscarinic receptor sites.
MANAGEMENT: It may be appropriate to avoid concomitant use of anticholinergic agents and cholinergic agents, depending on the needs of the patient. If concurrent use is necessary, the patient should be monitored for reduced pharmacologic effects of both drugs.
- "Product Information. Salagen Tablets (pilocarpine)." Boehringer-Ingelheim, Ridgefield, CT.
- Benjamin KW "Toxicity of ocular medications." Int Ophthalmol Clin 19 (1979): 199-255
Generic Name: olodaterol / tiotropium
Brand name: Stiolto Respimat 28 ACT, Stiolto Respimat 60 ACT, Stiolto Respimat 10 ACT, Stiolto Respimat
Synonyms: Olodaterol and tiotropium, Tiotropium and Olodaterol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Duvoid-Tiotropium Bromide
- Duvoid-Tiotropium Capsules for Inhalation
- Duvoid-Tiotropium inhalation
- Duvoid-Tiotropium Inhalation Spray
- Duvoid-Tiotropium Inhalation, oral/nebulization
- Duvoid-Tip-Lok Diluent flush
- Tiotropium and olodaterol Inhalation-Duzallo
- Tiotropium and olodaterol Inhalation-Dvorah
- Tiotropium and olodaterol Inhalation-DX1 OraGenomic Medicated DNA
- Tiotropium and olodaterol Inhalation-DX2 OraGenomic Medicated DNA
- Tiotropium and olodaterol Inhalation-Dxevo Tablets
- Tiotropium and olodaterol Inhalation-DY-G Liquid